A detailed history of Baystate Wealth Management LLC transactions in Haleon PLC stock. As of the latest transaction made, Baystate Wealth Management LLC holds 22 shares of HLN stock, worth $213. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22
Previous 22 -0.0%
Holding current value
$213
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 25, 2023

SELL
$7.85 - $8.94 $1,334 - $1,519
-170 Reduced 88.54%
22 $0
Q2 2023

Sep 21, 2023

BUY
$8.04 - $9.0 $1,543 - $1,728
192 New
192 $1,000
Q1 2023

Apr 25, 2023

BUY
$7.57 - $8.37 $1,445 - $1,598
191 New
191 $1,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Baystate Wealth Management LLC Portfolio

Follow Baystate Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baystate Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baystate Wealth Management LLC with notifications on news.